# Suzanne Angell

> Suzanne Angell is a Series B investor at Casdin Capital backing Genetics and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Casdin Capital](https://shizune.co/investors/profile/casdin-capital)
- Location: Solana Beach, United States
- Total investments: 1
- Last investment: Mar 2022
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/suzanne-angell-a369a24

Suzanne Angell is a Director of Research at Casdin Capital, LLC. He Attended The Johns Hopkins University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Genetics | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Emergency Medicine | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Celsius Therapeutics | Celsius Therapeutics develop life-changing medicines and discover critical biomarkers for patient care by better understanding the cellular ecosystem of diseases through Single Cell Genomics and Machine Learning. | $83M | Series B | Mar 24, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 2 deals together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 1 deal together
- [Amgen Ventures](https://shizune.co/investors/profile/amgen-ventures) — VC Fund, 1 deal together
- [Amplitude Venture Capital](https://shizune.co/investors/profile/amplitude-venture-capital) — VC Fund, 1 deal together
- [Catalio Capital Management](https://shizune.co/investors/profile/catalio-capital-management) — VC Fund, 1 deal together
- [Cowin Venture](https://shizune.co/investors/profile/cowin-venture) — VC Fund, 1 deal together

## About Casdin Capital

VC Fund · New York, United States

Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets undermanagement.

4 contacts available at Casdin Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Suzanne Angell | Director of Research | https://shizune.co/investors/profile/suzanne-angell-fb8b |
| Eli Casdin | managing partner | https://shizune.co/investors/profile/eli-casdin |
| John Graziano | Platform Investor Relations & Syndication Lead | https://shizune.co/investors/profile/john-graziano-6430 |
| Lawrence Canzoneri | CFO | https://shizune.co/investors/profile/lawrence-canzoneri |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Suzanne Angell invest in?

Suzanne Angell invests primarily in Genetics, Health Care and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Suzanne Angell last invest?

The most recent investment recorded for Suzanne Angell closed in Mar 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co